Thermo Fisher Bioproduction Solutions

  1. How Can You Actively Reduce Particulate Burden In Your Workflow? 8/4/2026

    Particulate control starts with practical decisions. Learn how material selection, acceptance criteria, and operator handling practices can help reduce contamination risk and support stronger quality.

  2. Nalgene Low And Ultralow Particulate Containers 8/4/2026

    Choose the right level of clean for bioproduction storage and transport, with options designed to help manage particulate, endotoxin, sterility and material requirements across critical workflows.

  3. Standard Single-Use Bottle Assembly Systems 8/4/2026

    Simplify fluid transfer workflows with ready-to-use, gamma-irradiated bottle assemblies designed to reduce setup, cleaning, and contamination concerns across media or buffer transfer applications.

  4. Enabling Flexibility For T Cell Isolation And Activation Using Workflows 7/16/2026

    Modular manufacturing strategies can support scalable T-cell processing while maintaining key quality measures. Explore how workflow design choices can help balance efficiency and performance.

  5. Consistone Yeast Extract UF: Batch Versus Fed-Batch Processing 7/10/2026

    Gain insight into how targeted nutrient supplementation increased CHO cell growth, boosted antibody production, and improved glycosylation profiles across batch and fed-batch cultures.

  6. From Process Development To QC—Optimize Your mAbs Workflow 5/29/2026

    See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.

  7. CHO Residual DNA Quantitation 5/29/2026

    Highly sensitive detection of trace DNA impurities supports safer manufacturing. Combining rapid workflows, strong specificity, and reliable recovery from complex samples enables confident monitoring.

  8. Leading The Way In Rapid Quantitation Of Host Cell DNA 5/29/2026

    Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.

  9. Advancing Cell Therapy With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Closed, automated T cell isolation with greater than 85% efficiency and greater than 96% purity is now achievable in 70 to 100 minutes, with cGMP-ready scalability from research to clinical manufacturing.

  10. Cell Therapy: T Cell Isolation From Whole Blood 4/21/2026

    Whole blood offers a faster, lower-cost starting material for T cell isolation and CTS Detachable Dynabeads CD4/CD8 with the DynaCellect System make it a viable, cGMP-aligned option without preprocessing.